BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bendapudi PK, Hurwitz S, Fry A, Marques MB, Waldo SW, Li A, Sun L, Upadhyay V, Hamdan A, Brunner AM, Gansner JM, Viswanathan S, Kaufman RM, Uhl L, Stowell CP, Dzik WH, Makar RS. Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study. Lancet Haematol. 2017;4:e157-e164. [PMID: 28259520 DOI: 10.1016/s2352-3026(17)30026-1] [Cited by in Crossref: 140] [Cited by in F6Publishing: 54] [Article Influence: 28.0] [Reference Citation Analysis]
Number Citing Articles
1 McFarlane PA, Bitzan M, Broome C, Baran D, Garland J, Girard LP, Grewal K, Lapeyraque AL, Patriquin CJ, Pavenski K, Licht C. Making the Correct Diagnosis in Thrombotic Microangiopathy: A Narrative Review. Can J Kidney Health Dis 2021;8:20543581211008707. [PMID: 33996107 DOI: 10.1177/20543581211008707] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int 2021;100:S1-S276. [PMID: 34556256 DOI: 10.1016/j.kint.2021.05.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
3 Chiasakul T, Cuker A. Clinical and laboratory diagnosis of TTP: an integrated approach. Hematology Am Soc Hematol Educ Program 2018;2018:530-8. [PMID: 30504354 DOI: 10.1182/asheducation-2018.1.530] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 12.0] [Reference Citation Analysis]
4 Tenison E, Asif A, Sheridan M. Congenital thrombotic thrombocytopenic purpura presenting in adulthood with recurrent cerebrovascular events. BMJ Case Rep 2019;12:e229481. [PMID: 31585956 DOI: 10.1136/bcr-2019-229481] [Reference Citation Analysis]
5 Mancini I, Agosti P, Boscarino M, Ferrari B, Artoni A, Palla R, Spreafico M, Crovetti G, Volpato E, Rossini S, Novelli C, Gattillo S, Barcella L, Salmoiraghi M, Falanga A, Peyvandi F; Lombardy AREU TMA Network. Lombardy diagnostic and therapeutic network of thrombotic microangiopathy. Orphanet J Rare Dis 2022;17:246. [PMID: 35739601 DOI: 10.1186/s13023-022-02400-y] [Reference Citation Analysis]
6 Zhou L, Zhu Y, Jiang M, Su J, Liu X, Jiang Y, Mu H, Yin J, Yang L, Liu H, Pan W, Su M, Liu H. Pregnancy-associated thrombotic thrombocytopenic purpura complicated by Sjögren's syndrome and non-neutralising antibodies to ADAMTS13: a case report. BMC Pregnancy Childbirth 2021;21:804. [PMID: 34861845 DOI: 10.1186/s12884-021-04167-9] [Reference Citation Analysis]
7 Huang MJ, Deng JN, Gao LL, Zhou JF. Thrombotic thrombocytopenic purpura complicated with acute aortic dissection: A case report. Medicine (Baltimore) 2021;100:e27898. [PMID: 34797341 DOI: 10.1097/MD.0000000000027898] [Reference Citation Analysis]
8 Subhan M, Scully M. Advances in the management of TTP. Blood Reviews 2022. [DOI: 10.1016/j.blre.2022.100945] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Reeves HM, Maitta RW. Comparison of absolute immature platelet count to the PLASMIC score at presentation in predicting ADAMTS13 deficiency in suspected thrombotic thrombocytopenic purpura. Thrombosis Research 2022. [DOI: 10.1016/j.thromres.2022.05.008] [Reference Citation Analysis]
10 Wathieu H, Bateman KM. A Case of Pseudothrombotic Microangiopathy Associated with Pernicious Anemia. J Gen Intern Med 2021;36:1775-7. [PMID: 33620630 DOI: 10.1007/s11606-020-06588-2] [Reference Citation Analysis]
11 Blasco M, Guillén E, Quintana LF, Garcia-Herrera A, Piñeiro G, Poch E, Carreras E, Campistol JM, Diaz-Ricart M, Palomo M. Thrombotic microangiopathies assessment: mind the complement. Clin Kidney J 2021;14:1055-66. [PMID: 33841853 DOI: 10.1093/ckj/sfaa195] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Vincent JL, Castro P, Hunt BJ, Jörres A, Praga M, Rojas-Suarez J, Watanabe E. Thrombocytopenia in the ICU: disseminated intravascular coagulation and thrombotic microangiopathies-what intensivists need to know. Crit Care 2018;22:158. [PMID: 29895296 DOI: 10.1186/s13054-018-2073-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 6.5] [Reference Citation Analysis]
13 Long B, Bridwell RE, Manchanda S, Gottlieb M. Evaluation and Management of Thrombotic Thrombocytopenic Purpura in the Emergency Department. J Emerg Med 2021;61:674-82. [PMID: 34518045 DOI: 10.1016/j.jemermed.2021.07.045] [Reference Citation Analysis]
14 Tripiciano C, Zangari P, Montanari M, Leone G, Massella L, Garaboldi L, Massoud M, Lancellotti S, Strocchio L, Manno EC, Palma P, Corsetti T, Luciani M. Case Report: Two Cases of Pediatric Thrombotic Thrombocytopenic Purpura Treated With Combined Therapy. Front Pediatr 2021;9:743206. [PMID: 34796152 DOI: 10.3389/fped.2021.743206] [Reference Citation Analysis]
15 Ben Saida I, Maatouk I, Toumi R, Bouslama E, Ben Ismail H, Ben Salem C, Boussarsar M. Acquired Thrombotic Thrombocytopenic Purpura Following Inactivated COVID-19 Vaccines: Two Case Reports and a Short Literature Review. Vaccines 2022;10:1012. [DOI: 10.3390/vaccines10071012] [Reference Citation Analysis]
16 Ayanambakkam A, Owens KC, McIntosh JJ, Nester CM, George JN. A postpartum perfect storm. Am J Hematol 2017;92:1105-10. [PMID: 28699161 DOI: 10.1002/ajh.24848] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
17 Shi W, Lv J, Lin L. Coagulopathy in COVID-19: Focus on vascular thrombotic events. J Mol Cell Cardiol 2020;146:32-40. [PMID: 32681845 DOI: 10.1016/j.yjmcc.2020.07.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
18 Louw S, Gounden R, Mayne ES. Thrombotic thrombocytopenic purpura (TTP)-like syndrome in the HIV era. Thromb J 2018;16:35. [PMID: 30559606 DOI: 10.1186/s12959-018-0189-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
19 Ho M, Zanwar S, Gertz MA. 44-Year-Old Man With Anemia, Thrombocytopenia, and Acute Kidney Injury. Mayo Clin Proc 2021:S0025-6196(21)00715-1. [PMID: 34862074 DOI: 10.1016/j.mayocp.2021.05.032] [Reference Citation Analysis]
20 Völker LA, Kaufeld J, Miesbach W, Brähler S, Reinhardt M, Kühne L, Mühlfeld A, Schreiber A, Gaedeke J, Tölle M, Jabs WJ, Özcan F, Markau S, Girndt M, Bauer F, Westhoff TH, Felten H, Hausberg M, Brand M, Gerth J, Bieringer M, Bommer M, Zschiedrich S, Schneider J, Elitok S, Gawlik A, Gäckler A, Kribben A, Schwenger V, Schoenermarck U, Roeder M, Radermacher J, Bramstedt J, Morgner A, Herbst R, Harth A, Potthoff SA, von Auer C, Wendt R, Christ H, Brinkkoetter PT, Menne J. Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura. Blood Adv 2020;4:3085-92. [PMID: 32634236 DOI: 10.1182/bloodadvances.2020001973] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 26.0] [Reference Citation Analysis]
21 Okabe M, Nakashima D, Matsuo N, Maruyama Y, Yokoo T. A case of subacute-onset myelodysplastic syndrome with infection mimicking thrombotic thrombocytopenic purpura: a case report with literature review. Ren Replace Ther 2019;5. [DOI: 10.1186/s41100-019-0208-9] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Azoulay E, Bauer PR, Mariotte E, Russell L, Knoebl P, Martin-Loeches I, Pène F, Puxty K, Povoa P, Barratt-Due A, Garnacho-Montero J, Wendon J, Munshi L, Benoit D, von Bergwelt-Baildon M, Maggiorini M, Coppo P, Cataland S, Veyradier A, Van de Louw A; Nine-i Investigators. Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura. Intensive Care Med 2019;45:1518-39. [PMID: 31588978 DOI: 10.1007/s00134-019-05736-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
23 Reddy MS, Newsom N, Sakurai S, Park SY, Reisch J, Sarode R. Performance of the PLASMIC score is improved with a positive score defined as ≥5 and with the inclusion of neurological symptoms. Br J Haematol 2022. [PMID: 35261027 DOI: 10.1111/bjh.18123] [Reference Citation Analysis]
24 Osti N, Beschin G, Goldin M, Guidolin L, Panero E, Sartori A, Parisi A, Cantini M, Pizzolo F, Olivieri O, Friso S. Case Report: Microangiopathic Hemolytic Anemia With Normal ADAMTS13 Activity. Front Med (Lausanne) 2021;8:589423. [PMID: 33738292 DOI: 10.3389/fmed.2021.589423] [Reference Citation Analysis]
25 Oliveira DS, Lima TG, Benevides FLN, Barbosa SAT, Oliveira MA, Boris NP, Silva HF. Plasmic score applicability for the diagnosis of thrombotic microangiopathy associated with ADAMTS13-acquired deficiency in a developing country. Hematol Transfus Cell Ther 2019;41:119-24. [PMID: 31079658 DOI: 10.1016/j.htct.2018.10.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
26 Oh J, Oh D, Lee SJ, Kim JO, Kim NK, Chong SY, Huh JY, Baker RI; Korean TTP Registry Investigators. Prognostic utility of ADAMTS13 activity for the atypical hemolytic uremic syndrome (aHUS) and comparison of complement serology between aHUS and thrombotic thrombocytopenic purpura. Blood Res 2019;54:218-28. [PMID: 31730685 DOI: 10.5045/br.2019.54.3.218] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
27 Milon V, Fage N, Guibert F, Frémeaux-Bacchi V, Augusto JF, Brilland B. Thrombotic microangiopathy with mild renal involvement and profound thrombocytopenia: not all roads lead to thrombotic thrombocytopenic purpura. J Nephrol 2022. [PMID: 35318588 DOI: 10.1007/s40620-022-01289-x] [Reference Citation Analysis]
28 Buetler VA, Agbariah N, Schild DP, Liechti FD, Wieland A, Andina N, Hammann F, Kremer Hovinga JA. Immune-Mediated Thrombotic Thrombocytopenic Purpura Following mRNA-Based COVID-19 Vaccine BNT162b2: Case Report and Mini-Review of the Literature. Front Med (Lausanne) 2022;9:890661. [PMID: 35655852 DOI: 10.3389/fmed.2022.890661] [Reference Citation Analysis]
29 Yin J, Yu ZQ, Kong DQ, Wang ZY, Jin J, Wang J, Wang XM, Su J, Zhang W, Ruan CG. [The diagnostic value of PLASMIC score in the discrimination between thrombotic thrombocytopenic purpura and disseminated intravascular coagulation]. Zhonghua Xue Ye Xue Za Zhi 2018;39:812-6. [PMID: 30369201 DOI: 10.3760/cma.j.issn.0253-2727.2018.10.005] [Reference Citation Analysis]
30 Berger AK, Allgäuer M, Apostolidis L, Schulze-Schleithoff AE, Merle U, Jaeger D, Haag GM. Cancer-related microangiopathic hemolytic anemia in patients with advanced gastric cancer: A retrospective single-center analysis. World J Gastrointest Oncol 2020; 12(11): 1288-1295 [PMID: 33250961 DOI: 10.4251/wjgo.v12.i11.1288] [Cited by in CrossRef: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Bae SH, Kim SH, Bang SM. Recent advances in the management of immune-mediated thrombotic thrombocytopenic purpura. Blood Res 2022;57:37-43. [PMID: 35483924 DOI: 10.5045/br.2022.2022005] [Reference Citation Analysis]
32 Gogia P, Gbujie E, Benge E, Bhasin S. Thrombotic Thrombocytopenic Purpura: Revisiting a Miss and an Inevitable Consequence. Cureus 2020;12:e9283. [PMID: 32699732 DOI: 10.7759/cureus.9283] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Shankar K, Huffman DL, Peterson C, Yasir M, Kaplan R. A Case of COVID-19 Induced Thrombotic Thrombocytopenic Purpura. Cureus 2021;13:e16311. [PMID: 34405070 DOI: 10.7759/cureus.16311] [Reference Citation Analysis]
34 Leaf RK, Dhami RS, Chun NS, Ta R. Case 11-2022: An 80-Year-Old Woman with Pancytopenia. N Engl J Med 2022;386:1453-61. [PMID: 35417641 DOI: 10.1056/NEJMcpc2201232] [Reference Citation Analysis]
35 Arıkan F, Yıldız Y, Ercan T, Oruç Ö, Akçay S, Yılmaz F, Toptaş T, Tuğlular T. Hydroxychloroquine-Associated Thrombotic Thrombocytopenic Purpura. Turk J Haematol 2020;37:302-4. [PMID: 32702948 DOI: 10.4274/tjh.galenos.2020.2020.0322] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Joseph A, Eloit M, Azoulay E, Kaplanski G, Provot F, Presne C, Wynckel A, Grangé S, Rondeau É, Pène F, Delmas Y, Lautrette A, Barbet C, Mousson C, Coindre J, Perez P, Jamme M, Augusto J, Poullin P, Jacobs F, El Karoui K, Vigneau C, Ulrich M, Kanouni T, Le Quintrec M, Hamidou M, Ville S, Charvet‐rumpler A, Ojeda‐uribe M, Godmer P, Fremeaux‐bacchi V, Veyradier A, Halimi J, Coppo P. Immune‐mediated thrombotic thrombocytopenic purpura prognosis is affected by blood pressure. Res Pract Thromb Haemost 2022;6. [DOI: 10.1002/rth2.12702] [Reference Citation Analysis]
37 Artinger K, Hackl G, Schilcher G, Eisner F, Pollheimer MJ, Mache C, Weiss EC, Eller K, Eller P. The conundrum of postpartum thrombotic Microangiopathy: case report and considerations for management. BMC Nephrol 2019;20:91. [PMID: 30871486 DOI: 10.1186/s12882-019-1286-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
38 Baysal M, Ümit E, Kırkızlar HO, Demir AM. Comparison of Clinical Scoring Systems in the Management of Patients with Microangiopathic Hemolytic Anemia and Thrombocytopenia. Turk J Haematol 2021;38:64-8. [PMID: 33161686 DOI: 10.4274/tjh.galenos.2020.2020.0348] [Reference Citation Analysis]
39 Sterner RC, Rose WN. Unique Presentation of Bortezomib-Associated Thrombotic Microangiopathy Responsive to Therapeutic Plasma Exchange and Eculizumab Therapy. Hematology Reports 2022;14:119-25. [DOI: 10.3390/hematolrep14020018] [Reference Citation Analysis]
40 Scully M. Thrombocytopenia in hospitalized patients: approach to the patient with thrombotic microangiopathy. Hematology Am Soc Hematol Educ Program 2017;2017:651-9. [PMID: 29222317 DOI: 10.1182/asheducation-2017.1.651] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
41 Poullin P. [Treatment of immune-mediated thrombotic thrombocytopenic purpura: A decisive turning point]. Transfus Clin Biol 2021;28:380-5. [PMID: 34464709 DOI: 10.1016/j.tracli.2021.08.347] [Reference Citation Analysis]
42 Joseph A, Cointe A, Mariani Kurkdjian P, Rafat C, Hertig A. Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review. Toxins (Basel) 2020;12:E67. [PMID: 31973203 DOI: 10.3390/toxins12020067] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 16.0] [Reference Citation Analysis]
43 Wang XY, Yang RC. [Advances in the treatment of thrombotic thrombocytopenic purpura]. Zhonghua Xue Ye Xue Za Zhi 2019;40:1055-9. [PMID: 32023744 DOI: 10.3760/cma.j.issn.0253-2727.2019.12.020] [Reference Citation Analysis]
44 Li A, Khalighi PR, Wu Q, Garcia DA. External validation of the PLASMIC score: a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis and treatment. J Thromb Haemost 2018;16:164-9. [PMID: 29064619 DOI: 10.1111/jth.13882] [Cited by in Crossref: 41] [Cited by in F6Publishing: 27] [Article Influence: 8.2] [Reference Citation Analysis]
45 Farshad S, Kanaan C, Savedchuk S, Karmo DS, Halalau A, Swami A. Systemic Lupus Erythematosus (SLE) with Acute Nephritis, Antineutrophil Cytoplasmic Antibody- (ANCA-) Associated Vasculitis, and Thrombotic Thrombocytopenic Purpura (TTP): A Rare Case Report with Literature Review. Case Rep Rheumatol 2019;2019:8750306. [PMID: 31934484 DOI: 10.1155/2019/8750306] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
46 Matthews A, Yui J, Chiang EY, Pishko AM, Cuker A, Cucchiara BL, George D, Sayani F, Mullen MT. Cerebral Infarction due to Severe ADAMTS-13 Deficiency with Normal Hematological Parameters: A Potentially Cause of Cryptogenic Stroke. J Stroke Cerebrovasc Dis 2022;31:106431. [PMID: 35305536 DOI: 10.1016/j.jstrokecerebrovasdis.2022.106431] [Reference Citation Analysis]
47 Gavriilaki E, Koravou E, Chatziconstantinou T, Kalpadaki C, Printza N, Ximeri M, Christoforidou A, Karavalakis G, Kaliou M, Kalaitzidou V, Tassi I, Tzellou M, Touloumenidou T, Papalexandri A, Papathanasiou M, Syrigou A, Kioumi A, Liga M, Kaiafa G, Spyridonidis A, Kapsali E, Kollios K, Mandala E, Vlachaki E, Tsirigotis P, Papadaki E, Lalayanni C, Sakellari I, Anagnostopoulos A. Real-world data of thrombotic microangiopathy management: The key role of ADAMTS13 activity and complement testing. Thrombosis Update 2021;3:100043. [DOI: 10.1016/j.tru.2021.100043] [Reference Citation Analysis]
48 Hawkins J, Aster RH, Curtis BR. Post-Transfusion Purpura: Current Perspectives. J Blood Med 2019;10:405-15. [PMID: 31849555 DOI: 10.2147/JBM.S189176] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
49 Zheng XL, Vesely SK, Cataland SR, Coppo P, Geldziler B, Iorio A, Matsumoto M, Mustafa RA, Pai M, Rock G, Russell L, Tarawneh R, Valdes J, Peyvandi F. ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura. J Thromb Haemost 2020;18:2486-95. [PMID: 32914582 DOI: 10.1111/jth.15006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
50 Lee C, Huang Y, Li S, Hsu Y, Chen Y, Chen T. Application of PLASMIC Score in Risk Prediction of Thrombotic Thrombocytopenic Purpura: Real-World Experience From a Tertiary Medical Center in Taiwan. Front Med 2022;9:893273. [DOI: 10.3389/fmed.2022.893273] [Reference Citation Analysis]
51 Al-Ahmad M, Al-Rasheed M, Shalaby NAB. Acquired thrombotic thrombocytopenic purpura with possible association with AstraZeneca-Oxford COVID-19 vaccine. EJHaem 2021. [PMID: 34226899 DOI: 10.1002/jha2.219] [Reference Citation Analysis]
52 Palandri F, Di Pietro C, Ricci F, Tazzari PL, Randi V, Bartoletti D, Cavo M, Vianelli N, Auteri G. Immune thrombotic thrombocytopenic purpura: Personalized therapy using ADAMTS-13 activity and autoantibodies. Res Pract Thromb Haemost 2021;5:e12606. [PMID: 34938937 DOI: 10.1002/rth2.12606] [Reference Citation Analysis]
53 Kucukyurt S, Eskazan AE. Assessment and Monitoring of Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP): Strategies to Improve Outcomes. J Blood Med 2020;11:319-26. [PMID: 33061729 DOI: 10.2147/JBM.S205630] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Karsenty CL, Kirk SE, Helber HL, Esquilin JM, Despotovic JM, Grimes AB. Molecular Diagnosis Is Vital to the Accurate Classification and Management of Thrombotic Thrombocytopenic Purpura in Children. Front Immunol 2022;13:836960. [DOI: 10.3389/fimmu.2022.836960] [Reference Citation Analysis]
55 Ramachandran P, Erdinc B, Abowali HA, Zahid U, Gotlieb V, Spitalewitz S. High Incidence of Thrombotic Thrombocytopenic Purpura Exacerbation Rate Among Patients With Morbid Obesity and Drug Abuse. Cureus 2021;13:e14656. [PMID: 34055510 DOI: 10.7759/cureus.14656] [Reference Citation Analysis]
56 Zini G, De Cristofaro R. Diagnostic Testing for Differential Diagnosis in Thrombotic Microangiopathies. Turk J Haematol 2019;36:222-9. [PMID: 31337190 DOI: 10.4274/tjh.galenos.2019.2019.0165] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
57 Balduini C, Freson K, Greinacher A, Gresele P, Kühne T, Scully M, Bakchoul T, Coppo P, Dovc Drnovsek T, Godeau B, Gruel Y, Rao AK, Kremer Hovinga JA, Makris M, Matzdorff A, Mumford A, Pecci A, Raslova H, Rivera J, Roberts I, Scharf RE, Semple JW, Van Geet C. The EHA Research Roadmap: Platelet Disorders. Hemasphere 2021;5:e601. [PMID: 34476343 DOI: 10.1097/HS9.0000000000000601] [Reference Citation Analysis]
58 Kim CH, Simmons SC, Williams LA III, Staley EM, Zheng XL, Pham HP. ADAMTS13 test and/or PLASMIC clinical score in management of acquired thrombotic thrombocytopenic purpura: a cost-effective analysis. Transfusion 2017;57:2609-18. [PMID: 28646526 DOI: 10.1111/trf.14230] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
59 Schönermarck U, Ries W, Schröppel B, Pape L, Dunaj-Kazmierowska M, Burst V, Mitzner S, Basara N, Starck M, Schmidbauer D, Mellmann A, Dittmer R, Jeglitsch M, Haas CS. Relative incidence of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome in clinically suspected cases of thrombotic microangiopathy. Clin Kidney J 2020;13:208-16. [PMID: 32296526 DOI: 10.1093/ckj/sfz066] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
60 Coppo P, Cuker A, George JN. Thrombotic thrombocytopenic purpura: Toward targeted therapy and precision medicine. Res Pract Thromb Haemost 2019;3:26-37. [PMID: 30656273 DOI: 10.1002/rth2.12160] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
61 Sukumar S, Gavriilaki E, Chaturvedi S. Updates on thrombotic thrombocytopenic purpura: Recent developments in pathogenesis, treatment and survivorship. Thrombosis Update 2021;5:100062. [DOI: 10.1016/j.tru.2021.100062] [Reference Citation Analysis]
62 Chowdhury A, Griffith MP, Busse E, Pasha AK. Postoperative Atypical Hemolytic Uremic Syndrome in a 67-Year-Old Woman Associated with Hemolytic Anemia, Thrombocytopenia, and Acute Renal Failure. Am J Case Rep 2020;21:e925662. [PMID: 33335086 DOI: 10.12659/AJCR.925662] [Reference Citation Analysis]
63 Louw S, Jacobson BF, Wiggill TM, Chapanduka Z, Sarah Mayne E. HIV‐associated thrombotic thrombocytopenic purpura (HIV‐TTP): A practical guide and review of the literature. HIV Medicine. [DOI: 10.1111/hiv.13305] [Reference Citation Analysis]
64 Uchino K, Sakai K, Shinohara S, Matsuhisa A, Iida Y, Nakano Y, Matsumura S, Kanasugi J, Takasugi S, Nakamura A, Horio T, Murakami S, Mizuno S, Yamamoto H, Hanamura I, Matsumoto M, Takami A. Successful preventive treatment with cyclosporine in a patient with relapsed/refractory immune-mediated thrombotic thrombocytopenic purpura: a case report and review of the literature. Int J Hematol 2022. [PMID: 35274194 DOI: 10.1007/s12185-022-03319-7] [Reference Citation Analysis]
65 Burguet L, Taton B, Prezelin-Reydit M, Rubin S, Picard W, Gruson D, Ryman A, Contin-Bordes C, Coppo P, Combe C, Delmas Y. Urine Protein/Creatinine Ratio in Thrombotic Microangiopathies: A Simple Test to Facilitate Thrombotic Thrombocytopenic Purpura and Hemolytic and Uremic Syndrome Diagnosis. J Clin Med 2022;11:648. [PMID: 35160098 DOI: 10.3390/jcm11030648] [Reference Citation Analysis]
66 George JN. The remarkable diversity of thrombotic thrombocytopenic purpura: a perspective. Blood Adv 2018;2:1510-6. [PMID: 29945940 DOI: 10.1182/bloodadvances.2018018432] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
67 van Dorland HA, Taleghani MM, Sakai K, Friedman KD, George JN, Hrachovinova I, Knöbl PN, von Krogh AS, Schneppenheim R, Aebi-Huber I, Bütikofer L, Largiadèr CR, Cermakova Z, Kokame K, Miyata T, Yagi H, Terrell DR, Vesely SK, Matsumoto M, Lämmle B, Fujimura Y, Kremer Hovinga JA; Hereditary TTP Registry. The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017. Haematologica 2019;104:2107-15. [PMID: 30792199 DOI: 10.3324/haematol.2019.216796] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 11.7] [Reference Citation Analysis]
68 Dane K, Chaturvedi S. Beyond plasma exchange: novel therapies for thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program 2018;2018:539-47. [PMID: 30504355 DOI: 10.1182/asheducation-2018.1.539] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
69 El-Gamal RA, Mekawy MA, Abd Elkader AM, Abdelbary HM, Fayek MZ. Combined Immature Platelet Fraction and Schistocyte Count to Differentiate Pregnancy-Associated Thrombotic Thrombocytopenic Purpura from Severe Preeclampsia/Haemolysis, Elevated Liver Enzymes, and Low Platelet Syndrome (SPE/HELLP). Indian J Hematol Blood Transfus 2020;36:316-23. [PMID: 32425383 DOI: 10.1007/s12288-019-01200-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
70 Graça NAG, Joly BS, Voorberg J, Vanhoorelbeke K, Béranger N, Veyradier A, Coppo P. TTP: From empiricism for an enigmatic disease to targeted molecular therapies. Br J Haematol 2022. [PMID: 35146746 DOI: 10.1111/bjh.18040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Avery EJ, Kenney SP, Byers BD, McIntosh JJ, Hoover C, Jiang Y, Xia L, Yu Z, George JN. Thrombotic thrombocytopenic purpura masquerading as preclampsia with severe features at 13 weeks' gestation. Am J Hematol 2020. [PMID: 32602158 DOI: 10.1002/ajh.25914] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
72 Huang Y, Li W, Macheret F, Gabriel RA, Ohno-Machado L. A tutorial on calibration measurements and calibration models for clinical prediction models. J Am Med Inform Assoc 2020;27:621-33. [PMID: 32106284 DOI: 10.1093/jamia/ocz228] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 22.0] [Reference Citation Analysis]
73 Zheng XL. The standard of care for immune thrombotic thrombocytopenic purpura today. J Thromb Haemost 2021;19:1864-71. [PMID: 34060225 DOI: 10.1111/jth.15406] [Reference Citation Analysis]
74 Karabulut K, Andronikashvili A, Kapici AH. Recurrence of Thrombotic Thrombocytopenic Purpura after mRNA-1273 COVID-19 Vaccine Administered Shortly after COVID-19. Case Rep Hematol 2021;2021:4130138. [PMID: 34552799 DOI: 10.1155/2021/4130138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
75 Lin Q, Fan L, Huang H, Zeng F, Fu D, Wei S. Combination of Fresh Frozen Plasma and Cryosupernatant Plasma for Therapeutic Plasma Exchange in Thrombotic Thrombocytopenic Purpura: A Single Institution Experience. Biomed Res Int 2019;2019:1756109. [PMID: 30834255 DOI: 10.1155/2019/1756109] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
76 Perez Botero J, Reese JA, George JN, McIntosh JJ. Severe thrombocytopenia and microangiopathic hemolytic anemia in pregnancy: A guide for the consulting hematologist. Am J Hematol 2021;96:1655-65. [PMID: 34424560 DOI: 10.1002/ajh.26328] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
77 Renaud A, Caristan A, Seguin A, Agard C, Blonz G, Canet E, Eveillard M, Godmer P, Graveleau J, Lecouffe-Desprets M, Maisonneuve H, Perrin F, Hamidou M, Néel A. Deleterious neurological impact of diagnostic delay in immune-mediated thrombotic thrombocytopenic purpura. PLoS One 2021;16:e0260196. [PMID: 34797873 DOI: 10.1371/journal.pone.0260196] [Reference Citation Analysis]
78 Ogilvie J, Singh J. A dramatic recovery in a patient initially expected to die of TTP & its complications. J Community Hosp Intern Med Perspect 2018;8:142-4. [PMID: 29915654 DOI: 10.1080/20009666.2018.1475186] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
79 Upadhyay VA, Geisler BP, Sun L, Uhl L, Kaufman RM, Stowell C, Makar RS, Bendapudi PK. Utilizing a PLASMIC score-based approach in the management of suspected immune thrombotic thrombocytopenic purpura: a cost minimization analysis within the Harvard TMA Research Collaborative. Br J Haematol 2019;186:490-8. [PMID: 31131442 DOI: 10.1111/bjh.15932] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
80 Sukumar S, Lämmle B, Cataland SR. Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management. J Clin Med 2021;10:536. [PMID: 33540569 DOI: 10.3390/jcm10030536] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
81 Sravanthi MV, Suma Kumaran S, Sharma N, Bojanapally P. A Rare Case of Acquired Thrombotic Thrombocytopenic Purpura Triggered by Acute Pancreatitis. Cureus 2020;12:e8477. [PMID: 32642381 DOI: 10.7759/cureus.8477] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
82 Chang SM, Gondim M, Huang M. Vitamin B12 malabsorption and pseudo- thrombotic microangiopathy in an adolescent. Thrombosis Update 2021;2:100032. [DOI: 10.1016/j.tru.2021.100032] [Reference Citation Analysis]
83 Di M, Bian J, Butera JN. A new onset of thrombocytopenia and microangiopathic hemolytic anemia in the healthcare setting: A challenge for diagnosis. Am J Hematol 2019;94:145-8. [PMID: 30264862 DOI: 10.1002/ajh.25298] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
84 Martin SD, McGinnis E, Smith TW. Indicators Differentiating Thrombotic Thrombocytopenic Purpura From Other Thrombotic Microangiopathies in a Canadian Apheresis Referral Center. Am J Clin Pathol 2021;156:1103-12. [PMID: 34160013 DOI: 10.1093/ajcp/aqab078] [Reference Citation Analysis]
85 Palma LMP, Vaisbich-Guimarães MH, Sridharan M, Tran CL, Sethi S. Thrombotic microangiopathy in children. Pediatr Nephrol 2022. [PMID: 35041041 DOI: 10.1007/s00467-021-05370-8] [Reference Citation Analysis]
86 Abou‐ismail MY, Kapoor S, Citla Sridhar D, Nayak L, Ahuja S. Thrombotic microangiopathies: An illustrated review. Res Pract Thromb Haemost 2022;6. [DOI: 10.1002/rth2.12708] [Reference Citation Analysis]
87 Ayanambakkam A, Kremer Hovinga JA, Vesely SK, George JN. Diagnosis of thrombotic thrombocytopenic purpura among patients with ADAMTS13 Activity 10%-20. Am J Hematol 2017;92:E644-6. [PMID: 28815685 DOI: 10.1002/ajh.24885] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
88 Maqsood MH, Rubab K, Maqsood MZ. Clinical Efficacy and Safety Profile of Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura. Cureus 2019;11:e5263. [PMID: 31576256 DOI: 10.7759/cureus.5263] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
89 Bray MA, Sartain SE, Gollamudi J, Rumbaut RE. Microvascular thrombosis: experimental and clinical implications. Transl Res 2020;225:105-30. [PMID: 32454092 DOI: 10.1016/j.trsl.2020.05.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
90 Fage N, Orvain C, Henry N, Mellaza C, Beloncle F, Tuffigo M, Geneviève F, Coppo P, Augusto JF, Brilland B. Proteinuria Increases the PLASMIC and French Scores Performance to Predict Thrombotic Thrombocytopenic Purpura in Patients With Thrombotic Microangiopathy Syndrome. Kidney International Reports 2021. [DOI: 10.1016/j.ekir.2021.11.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
91 Pisklakova A, Barbir J, Sambataro JP, Almanzar C, Manji F. Silent Thrombotic Thrombocytopenic Purpura: PLASMIC, Lessons Learned, and Current Management Overview. Cureus 2021;13:e13803. [PMID: 33842174 DOI: 10.7759/cureus.13803] [Reference Citation Analysis]
92 Krečak I, Tomac G, Škugor J, Gverić-Krečak V, Pulanić D. In vivo and in vitro cross-reactivity to fondaparinux in a stroke patient with IgG-PF4/heparin antibody-negative delayed-onset heparin-induced thrombocytopenia. Blood Transfus 2020;18:322-5. [PMID: 32530398 DOI: 10.2450/2020.0037-20] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
93 Harada Y, Komori I, Morinaga K, Shimizu T. Microangiopathic haemolytic anaemia with thrombocytopenia induced by vitamin B12 deficiency long term after gastrectomy. BMJ Case Rep 2018;2018:bcr-2018-225915. [PMID: 30232206 DOI: 10.1136/bcr-2018-225915] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
94 Palma LMP, Sridharan M, Sethi S. Complement in Secondary Thrombotic Microangiopathy. Kidney Int Rep 2021;6:11-23. [PMID: 33102952 DOI: 10.1016/j.ekir.2020.10.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
95 Venier LM, Patriquin CJ, Warkentin TE. Acute thrombocytopenia suggesting thrombotic microangiopathy. Am J Hematol 2022;97:659-65. [PMID: 35253925 DOI: 10.1002/ajh.26515] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Wang XY, Liu XF, Xue F, Liu W, Chen YF, Huang YT, Fu RF, Zhang L, Yang RC. [Clinical characteristics of 83 patients with thrombotic thrombocytopenic purpura]. Zhonghua Xue Ye Xue Za Zhi 2020;41:216-21. [PMID: 32311891 DOI: 10.3760/cma.j.issn.0253-2727.2020.03.006] [Reference Citation Analysis]
97 Li A, Kremer Hovinga JA. Laboratory surveillance of immune-mediated thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program 2020;2020:82-4. [PMID: 33275690 DOI: 10.1182/hematology.2020000164] [Reference Citation Analysis]
98 Saha M, McDaniel JK, Zheng XL. Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics. J Thromb Haemost 2017;15:1889-900. [PMID: 28662310 DOI: 10.1111/jth.13764] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 11.8] [Reference Citation Analysis]
99 Rogers BB, Zawislak C, Wong V. Management of Hematologic Adverse Events Associated With Immune Checkpoint Inhibitors. J Adv Pract Oncol 2021;12:392-404. [PMID: 34123476 DOI: 10.6004/jadpro.2021.12.4.4] [Reference Citation Analysis]
100 Schelpe AS, Roose E, Joly BS, Pareyn I, Mancini I, Biganzoli M, Deckmyn H, Voorberg J, Fijnheer R, Peyvandi F, De Meyer SF, Coppo P, Veyradier A, Vanhoorelbeke K. Generation of anti-idiotypic antibodies to detect anti-spacer antibody idiotopes in acute thrombotic thrombocytopenic purpura patients. Haematologica 2019;104:1268-76. [PMID: 30523052 DOI: 10.3324/haematol.2018.205666] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]